Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: Correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters

European Journal of Gynaecological Oncology

Volumn 25, Issue 6, 2004, Pages 719-724

  Mitselou, A ^a   Ioachim, E ^a   Zagorianakou, N ^a   Kitsiou, E ^b   Vougiouklakis, T ^a   Agnantis, N J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

Author keywords

Cyclin D1; Cyclin E; Endometrial carcinoma; p53, pRb

Indexed keywords

CYCLIN D1; CYCLIN E; HORMONE RECEPTOR; KI 67 ANTIGEN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; FEMALE; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; TUMOR SUPPRESSOR GENE;

CASE-CONTROL STUDIES; CYCLIN D1; CYCLIN E; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASM STAGING; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 9644262457     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. American Cancer Society: "Cancer Facts and Figures 2001". Atlanta, GA. Am. Cancer Soc., 2001.
2. Srivatse P.J., Cliby W., Keeney G.L., Suman V.J., Marsen W.S., Ziesmer S.C. et al.: "Expression of nm23/nucleoside diphosphate kinase A protein in endometrial carcinoma". Gynecol. Oncol., 1997, 66 (2), 238.
3. Milde-Langosch K., Bamberger A.M., Goemana C., Rossing E., Rieck G., Kelp B., Loning T.: "Expression of cell cyclin regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters". Cancer Res. Clin. Oncol., 2001, 127 (9), 544.
4. Nikaido T., Li S.F., Shiozawa T., Fujii S.: "Co-abnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas". Cancer, 1996, 78 (6), 1248.
5. Lees E.: "Cyclin dependent kinase regulation". Current Opin. Cell. Biol., 1995, 7 (6), 773.
6. Barbieri F., Cagnoli M., Ragni N., Pedulla F., Foglia G., Alama A.: "Expression of cyclin D1 correlates with malignancy in human ovarian tumors". Br. J. Cancer, 1997, 75 (9), 1263.
7. Jares P., Fernandez P.L., Campo E., Nadal A., Bosh F., Aiza G. et al.: "PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas". Cancer Res., 1994, 54 (17), 4813.
8. Gillett C., Fantl V., Smith R., Fisher Ch., Barteck J., Barnes D. et al.: "Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining". Cancer Res., 1994, 54 (7), 1812.
9. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., Pagano M.: "Human cyclin E, a nuclear protein for the G1 to S phase transition". Mol. Cell. Biol., 1995, 15 (5), 2612.
10. Koff A., Giordano A., Desai D., Yamashita K., Harper J.W., Elledge S. et al.: "Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle". Science, 1992, 257 (5077), 1689.
11. Jiang W., Zhang Y.J., Kahn S.M., Hollstein M.C., Santella R.M., Lu S.H. et al.: "Altered expression of the cyclin D1 and retinoblastoma genes in human oesophageal cancer". Proc. Natl. Acad. Sci. USA, 1993, 90 (12), 9026.
12. Creasman W.T.: "Announcement FIGO stages: Revision". Gynecol. Oncol., 1988, 35, 125.
13. nd ed., Berlin: Springer Verlag, 1998, 406.
14. Ito K., Sasano H., Yoshida Y., Sato S., Yajima A.: " Immunohistochemical study of cyclin D1 and E, and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma". Anticancer Res., 1998, 18 (13A), 1661.
15. Segreti E., Movotny D.B., Soper J.T., Mutch W.T., Creasman K.S., McCarty J.: "Endometrial cancer: histologic correlates of immunohistochemical localization of progesteron and oestrogen receptor". Obstet. Gynecol., 1989, 73, 780.
16. Sung C.J., Zheng Y., Quddus M.R., Kang X., Zhang Z.F., Laychland S.C. et al.: "p53 as a significant prognostic marker in endometrial carcinoma". Int. J. Gynecol. Cancer, 2000, 10 (21), 119.
17. Ioffe O.B., Papadimitriou J.C., Drachanberg C.B.: "Correlation of proliferative indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic and malignant endometrium". Hum. Pathol., 1998, 29 (10), 1150.
18. Ioachim E.E., Goussia A.C., Kitsiou E.G., Charalampopoulos K., Mermiga E., Stefanaki S.: "Immunohistochemical expression of retinoblastoma gene product in normal, hyperplastic and malignant endometrium. Correlation with p53 protein, c-erbB-2, hormone receptor status, and proliferative activity". Dis. Markers, 2000, 18 (3), 1.
19. McCluggage W.G.: "Recent advances in immunohistochemistry in gynaecological pathology". Histopathology, 2002, 40 (4), 309.
20. Quddus M.R., Latkovich P., Castellani W.J., Sung J., Steinhoff M.M. et al: "Expression of cyclin D1 in normal, metaplsatic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis". Arch. Pathol. Lab. Med., 2002, 126 (4), 459.
21. Wang T.C., Cardiff R.D., Zukerberg L., Less E., Arnold A., Schmidt E.V.: "Mammary hyperplasia and carcinoma in MMTV-cyclin D1 trangenic mice". Nature, 1994, 369 (6482), 669.
22. Fantl V., Richards M.A., Lammie G.A., Johnstone G., Allen D., Gregory W. et al.: "Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer". Eur. J. Cancer, 1990, 26 (4), 423.
23. Nielsen A.L., Nyholm H.C.: "The combination of p53 and age predict cancer specific in advanced stage of endometrial carcinoma of endometrioid type. An immunohistochemical examination of growth fraction: Ki67, MIB1, and PC10; suppressor oncogene protein p185 and age, hormone treatment, stage, and histologic grade". Eur. J. Obstet. Gynecol. Rep. Biol., 1996, 70 (1), 79.
24. Shiozawa T, Li S.F., Nakayama K., Nikaido T., Fujii S.: "Relationship between the expression of cyclins/cyclin-dependent kinases and sex steroid receptors, Ki67 in normal human endometrial glands and stoma during the menstrual cycle". Mol. Hum. Reprod., 1996, 2 (10), 745.
25. Zukerberg L.R., Ynag W.I., Gadd M., Thor A.D., Koerner F.C., Schmidt E.V. et al.: "Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene". Mod. Pathol., 1995, 8 (5), 560.
26. Kurzrock R., Ku S., Talpaz M.: "Abnormalities in the PRAD1 (cyclin D1/bcl-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma lines". Cancer, 1995, 75 (2), 584.
27. Barbieri F., Cagnoli M., Ragni N., Foglia G., Bruzzo C., Pedulla F., et al.: "Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors". Clin. Cancer Res., 1999, 5 (7), 1837.
28. Lee C.R., Yamamoto S., Morimura K., Wanibuchi H., Nishisaka N., Ikemoto S. et al.: "Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features". Cancer, 1997, 79 (4), 789.
29. Callender T., El Naggar A.K., Lee M.S., Frankerthaler R., Luna M.A., Batsakis J.G. et al.: "PRAD1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma". Cancer, 1994, 74 (1), 152.
30. Jares P., Rey M.J., Fernandez P.L., Campo E., Nadal A., Munoz M. et al.: "Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumor proliferation and oestrogen receptor status". J. Pathol., 1997, 182 (2), 160.
31. Xiong T., Zhang H., Beach D.: "Retinoblastoma gene product in tumorigenesis". Cell., 1993, 71, 505.
32. Jiang W., Zhang Y.J., Kahn S., Hollstein M.C., Santella R., Lu S.H. et al.: "Altered expression of the cyclin D1 and retinoblastoma genes in human oesophageal cancer". Prac. Natl. Acad. Sci. USA, 1993, 90 (19), 9026.
33. Heffner H.M., Freedman A.N., Asiwathan J.E., Lele S.B.: "Prognostic significance of p53, PCNA and c-erb-B-2 in endometrial carcinoma". Eur. J. Gynaecol. Oncol., 1999, 20 (1), 8.
34. Wang D.A., Konishi I., Koshiyama M., Mandai, Nambu Y., Ishikawa Y. et al.: "Expression of c-erbB-2 protein and epidermal growth factor receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid status". Cancer, 1993, 72 (1), 2628.
35. Session D.R., Lee O.S., Choi J., Wolgemuth D.J.: "Expression of cyclin E in gynaecological malignancies". Gynecol. Oncol., 1999, 72 (1), 32.
36. Milde-Langosh K.M., Hagen M., Bamberger A.M., Loning T.: "Expression and prognostic value of the cell cycle regulatory proteins, Rb, p16MST1, p21WAF1, p27KIP1, cyclin E and cyclin D2, in ovarian cancer". Int. J. Gynaecol. Pathol., 2003, 22 (2), 168.
37. Keyomarsi K., O'Leary N., Molnar G., Lees E., Fingert H.J., Pardee A.B.: "Cyclin E, a potential prognostic marker for breast cancer". Cancer Res., 1994, 54, 380.
38. Milde-Langosch K., Bamberger A.M., Mothner C.C., Rieck G., Loning T.: "Expression of cell cycle regulatory proteins Rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members". Int. J. Cancer, 2000, 87 (4), 468.
39. Courjal F., Louason G., Speiser P., Katsaros D., Zeillenger R., Theillet Ch.: "Cycline gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors". Int. J. Cancer, 1996, 69 (4), 247.
40. Li S.F., Shiozawa T., Nakayama K., Nikaido T., Fujii S.: "Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma". Cancer, 1996, 77 (2), 321.
41. Semeczuk A., Marzec B., Roessner A., Jakowicki J.A., Wojcierowski J., Schneider-Stock R.: "Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer". Virchows Arch., 2002, 441 (6), 577.
42. Classon M., Harlow E.: "The retinoblastoma tumor suppressor gene in development and cancer". Nature Rev. Cancer, 2002, 2 (12), 910.
43. Skomedal H., Kristensen G.B., Nesland J.M., Borrensen-Dale A.L., Trope C., Holm R.: "TP53 alterations in relation to the cell cycle associated proteins p21, cyclin D1-CDK4, RB, MDM2, and EGFR in cancer of the uterine corpus". J. Pathol., 1999, 187 (51), 556.
44. Tsuda H., Yamamoto K., Inoue T., Uchiyama I., Umesaki N.: "The role of p16 cyclin D/CDK-pRB pathway in the tumorigenesis of endometrioid type endometrial carcinoma". Br. J. Cancer, 2000, 82 (3), 675.